Sunday, August 31, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Arvinas NASDAQ ARVN Analyst Ratings and Price Targets A Dynamic Overview

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Financing and finances
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

After analyzing the opinions of 7 analysts, Arvinas (NASDAQ: ARVN) has received a mix of ratings ranging from bullish to bearish as of February 28, 2024.

In the last month, there were no bullish ratings, 2 somewhat bullish ratings, and no indifferent, somewhat bearish, or bearish ratings. This is a shift from the ratings one month prior, which included 1 bullish rating, no somewhat bullish ratings, 2 indifferent ratings, and no somewhat bearish or bearish ratings.

The average 12-month price target for Arvinas stands at $60.29, with a high estimate of $80.00 and a low estimate of $40.00. This marks a 29.94% increase from the previous average of $46.40.

Recent actions taken by analysts include:
– Robert Driscoll from Wedbush upgraded the rating to Outperform with a current price target of $59.00.
– Matthew Biegler from Oppenheimer downgraded the rating to Outperform with a price target of $80.00.
– Yigal Nochomovitz from Citigroup upgraded the rating to Neutral with a price target of $55.00.
– Paul Choi from Goldman Sachs initiated a Buy rating with a price target of $70.00.
– Derek Archila from Wells Fargo initiated an Overweight rating with a price target of $63.00.
– Akash Tewari from Jefferies upgraded the rating to Buy with a price target of $40.00.

These actions demonstrate the fluidity of analyst recommendations in response to market conditions and company performance, highlighting the dynamic nature of the financial landscape.

ARVN Stock Declines by 1.60% on February 28, 2024: Investors Advised to Monitor Performance Closely

On February 28, 2024, ARVN stock experienced a decline in its performance. The stock closed at $48.01, which was $0.78 lower than the previous closing price, representing a 1.60% drop in value. Additionally, in after-hours trading, the stock dropped even further by $0.96.

Despite this decline, ARVN is still trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well overall in the longer term, but the recent drop in price may be a cause for concern for investors.

It is important for investors to carefully monitor the performance of ARVN stock in the coming days to see if this downward trend continues or if the stock is able to rebound. Factors such as market conditions, company news, and industry trends can all impact the performance of a stock, so it is important to stay informed and make well-informed investment decisions.

ARVN Stock Performance Analysis: Mixed Results on February 28, 2024

On February 28, 2024, ARVN stock had mixed performances based on the financial data provided by CNN Money. The total revenue for the company was reported at $78.50 million for the past year, showing a decrease of 40.26% compared to the previous year. However, the total revenue remained unchanged from the last quarter at -$43.10 million.

Similarly, the net income for ARVN was reported at -$367.30 million for the past year, reflecting a decrease of 30.02% compared to the previous year. The net income also remained unchanged from the last quarter at -$154.80 million.

Earnings per share (EPS) for ARVN were reported at -$6.62 for the past year, showing a decrease of 24.63% compared to the previous year. The EPS also remained unchanged from the last quarter at -$2.53.

Overall, the financial performance of ARVN stock on February 28, 2024, was mixed with a significant decrease in total revenue, net income, and earnings per share compared to the previous year. However, the company managed to maintain its financial performance from the last quarter.

Tags: ARVN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Trading online

Analyst Sentiments Point to Positive Future for Arcutis Biotherapeutics

Pharmaceutical Market Capitalization

Developing a Promising Therapeutic Option for ObesityRelated Inflammation Inflammasome ASC Inhibitor IC 100

Biotechnology Markets and money

vTv Therapeutics Secures 51 Million Private Placement for Advancing Type 1 Diabetes Therapies

Recommended

U.S. Gold Stock

U.S. Gold Secures Critical Infrastructure Deal for Flagship Project

3 days ago
Finance_ Investing in stocks

INFINT Acquisition Corporation Fails to Meet NYSEs Minimum Shareholder Requirement

2 years ago
Technology Cloud computing Trading online

AgEagle Aerial Systems Implements Reverse Stock Split to Maintain NYSE American Listing

2 years ago

ArcherDanielsMidland Faces Setback as CFO Placed on Leave and Accounting Practices Investigated

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe ADSK Alibaba AMD AMZN Apple AVGO BA Broadcom C Coinbase COST CRWD DIS DWAC Eli Lilly GM IBM INTC Intel Kraft Heinz LLY Lockheed META Micron MP Materials MSFT NFLX NIO Nvidia NVO Opendoor Oracle Palantir PLTR Red Cat Robinhood Rocket Lab USA SMCI Strategy Tesla TGT Tilray TSLA
No Result
View All Result

Highlights

Paramount’s Strategic Reboot: A New Era with Skydance and UFC Partnership

Aldeyra Therapeutics Achieves Dual Regulatory Milestones for Key Drug Candidates

Semler Scientific’s High-Stakes Bitcoin Bet Faces Mounting Pressure

Analysts Maintain Strong Buy Ratings for Curis Despite Stock’s Steep Decline

Jazz Pharmaceuticals Secures Dual Regulatory Wins for Oncology Drug

Leadership Transition at Simmons First National Amid Major Financial Restructuring

Trending

AutoZone Stock
Automotive & E-Mobility

Leadership Transition at AutoZone Precedes Quarterly Earnings Announcement

by Robert Sasse
August 31, 2025
0

As AutoZone approaches its next quarterly earnings release, the automotive parts retailer is implementing significant executive changes....

FactSet Research Stock

FactSet Research Faces Critical Earnings Test Amid Market Pressures

August 31, 2025
Victory Capital Stock

Victory Capital: A Stealthy Acquisition Powerhouse in Asset Management?

August 31, 2025
Paramount Stock

Paramount’s Strategic Reboot: A New Era with Skydance and UFC Partnership

August 31, 2025
Aldeyra Therapeutics Stock

Aldeyra Therapeutics Achieves Dual Regulatory Milestones for Key Drug Candidates

August 31, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Leadership Transition at AutoZone Precedes Quarterly Earnings Announcement August 31, 2025
  • FactSet Research Faces Critical Earnings Test Amid Market Pressures August 31, 2025
  • Victory Capital: A Stealthy Acquisition Powerhouse in Asset Management? August 31, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com